Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Personalised cancer support app wins Janssen's digital prize

Px HealthcareCare takes first place, ahead of DrEd and Onco Drug Personalized Med

JHI Digital Health Masterclass ChallengeA mobile app that offers cancer patients personalised support has won Janssen's inaugural Digital Health Masterclass Challenge.

Px HealthCare took the €30,000 first prize at last week's Janssen Healthcare Innovation and Johnson & Johnson event, which saw 20 digital health start-ups from nine European countries pitch to a panel of experts and investors.

The Amsterdam-based company's OWise app is designed to improve patient-doctor relationships, with a current focus on breast cancer, and aggregates user data for real-world evidence of drug side effects and interactions.

Janssen Healthcare Innovation, an entrepreneurial team within Janssen's R&D arm, said Px HealthCare's cutting-edge technology” highlights how digital health businesses across Europe are fast securing their position as key players in today's health ecosystem”.

JHI Digital Health Masterclass Challenge winner Px HealthCare
Pictured from left: J&J's Pat Smallcombe and Marco Mohwinckel, Px HealthCare's Anne Bruinvels and J&J's Shawn Luetchens

Placed second and third in the competition were DrEd and Onco Drug Personalized Med (ODPM), taking prizes of €15,000 and €5,000 respectively.

Online doctor service DrEd currently operates out of the UK, Germany, Austria and Switzerland and provides remote medical consultations for a range of conditions, including sexual health testing and travel health.

France-based company ODPM, meanwhile, develops web-based toxicity calculators for patients receiving treatment with fluoropyrimidines to ensure they receive the right dose. This helps improve their quality of life during chemotherapy and can reduce hospital costs.

Marco Mohwinckel, a partner at Janssen Healthcare Innovation, said: “We want to congratulate not just the winners of this award, but all 20 companies who were selected to take part in the Digital Health Masterclass Challenge. The judging panel was hugely impressed by the digital healthcare solutions demonstrated by all the participating companies. Reaching a final decision was not easy.”

Janssen received over 100 applicants for its Masterclass and the 20 start-ups selected participated in three sessions in Berlin, Barcelona and London. Part of the sessions brought the companies together with customers, international influencers, executives from the Johnson & Johnson Family of Companies and investors.

Patrick Verheyen, head of Johnson & Johnson Innovation, London, said: “Connecting innovators with the right resources has the potential to accelerate new health solutions and improve the lives of patients. By pooling the expertise across the Johnson & Johnson Family of Companies, we can be a catalyst to these rising stars of digital health and others in the innovation ecosystem.”

27th November 2013

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Dimitri Azzopardi
Case-study for thalassaemia: Dimitri Azzopardi
An in-depth look at beta thalassaemia for Rare Disease Day...
Delivering change through better rare disease communications
OPEN Health’s Richard Jones, Gemma Allen and Charlotte Richards discuss how pharma can utilise tools, channels and stakeholders to deliver change and enable better outcomes....
Interim analysis clinical trials
Assessing the value of interim analyses in clinical trials
Why its important and when its needed...

Infographics